Donald E Bobo Jr is CVP,Strategy/Corp Development of Edwards Lifesciences Corp. Currently has a direct ownership of 46,935 shares of EW, which is worth approximately $3.41 Million. The most recent transaction as insider was on May 03, 2024, when has been sold 479 shares (Common Stock) at a price of $85.06 per share, resulting in proceeds of $40,743. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.9K
0% 3M change
18.82% 12M change
Total Value Held $3.41 Million

DONALD E BOBO Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2024
SELL
Payment of exercise price or tax liability
$40,743 $85.06 p/Share
479 Reduced 1.2%
39,288 Common Stock
Apr 08 2024
SELL
Open market or private sale
$1,156,250 $92.5 p/Share
12,500 Reduced 23.92%
39,767 Common Stock
Apr 08 2024
BUY
Exercise of conversion of derivative security
$459,375 $36.75 p/Share
12,500 Added 19.3%
52,267 Common Stock
Mar 13 2024
SELL
Open market or private sale
$1,319,645 $91.01 p/Share
14,500 Reduced 26.85%
39,502 Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
$532,875 $36.75 p/Share
14,500 Added 21.17%
54,002 Common Stock
Feb 13 2024
SELL
Open market or private sale
$946,880 $86.08 p/Share
11,000 Reduced 21.78%
39,502 Common Stock
Feb 13 2024
BUY
Exercise of conversion of derivative security
$404,250 $36.75 p/Share
11,000 Added 17.89%
50,502 Common Stock
Jan 12 2024
SELL
Open market or private sale
$756,700 $75.67 p/Share
10,000 Reduced 20.2%
39,502 Common Stock
Jan 12 2024
BUY
Exercise of conversion of derivative security
$367,500 $36.75 p/Share
10,000 Added 16.81%
49,502 Common Stock
Dec 13 2023
SELL
Open market or private sale
$574,880 $71.86 p/Share
8,000 Reduced 16.84%
39,502 Common Stock
Dec 13 2023
BUY
Exercise of conversion of derivative security
$294,000 $36.75 p/Share
8,000 Added 14.41%
47,502 Common Stock
Nov 13 2023
SELL
Open market or private sale
$391,140 $65.19 p/Share
6,000 Reduced 13.19%
39,502 Common Stock
Nov 13 2023
BUY
Exercise of conversion of derivative security
$220,500 $36.75 p/Share
6,000 Added 11.65%
45,502 Common Stock
Oct 13 2023
SELL
Open market or private sale
$349,600 $69.92 p/Share
5,000 Reduced 11.24%
39,502 Common Stock
Oct 13 2023
BUY
Exercise of conversion of derivative security
$183,750 $36.75 p/Share
5,000 Added 10.1%
44,502 Common Stock
Sep 14 2023
SELL
Open market or private sale
$331,695 $73.71 p/Share
4,500 Reduced 10.23%
39,502 Common Stock
Sep 14 2023
BUY
Exercise of conversion of derivative security
$165,375 $36.75 p/Share
4,500 Added 9.28%
44,002 Common Stock
Aug 14 2023
SELL
Open market or private sale
$356,850 $79.3 p/Share
4,500 Reduced 10.23%
39,502 Common Stock
Aug 14 2023
BUY
Exercise of conversion of derivative security
$165,375 $36.75 p/Share
4,500 Added 9.28%
44,002 Common Stock
Jul 14 2023
SELL
Open market or private sale
$325,290 $92.94 p/Share
3,500 Reduced 8.14%
39,502 Common Stock
Jul 14 2023
BUY
Exercise of conversion of derivative security
$128,625 $36.75 p/Share
3,500 Added 7.53%
43,002 Common Stock
Jun 14 2023
SELL
Open market or private sale
$314,195 $89.77 p/Share
3,500 Reduced 8.14%
39,502 Common Stock
Jun 14 2023
BUY
Exercise of conversion of derivative security
$128,625 $36.75 p/Share
3,500 Added 7.53%
43,002 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
6,425 Added 13.99%
39,502 Common Stock
May 10 2023
SELL
Open market or private sale
$223,050 $89.22 p/Share
2,500 Reduced 7.03%
33,077 Common Stock
DEB

Donald E Bobo Jr

CVP,Strategy/Corp Development
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW